Belgian Heart Foundation
- Project calls
- Young Investigator Award
- Dr. Leon Dumont Prize
- BHF Basic Research Grant
- BHF Clinical Research Grant
- BHF Cardio Oncology Grant
- BHF Sports Cardiology Grant
The 2022 submissions platform is closed -> next call in Q2 2023.
During the BSC Congress on Friday 10th February 2023, the achievements of the laureates of the Basic research, Clinical research and the Randomised clinical research trial, will be honoured during the Award ceremony.
Further information on the Belgian Heart Foundation can be found via the following link: BHF
2022 submission categories:
N° 1 – Basic research in cardiology (the two best projects will receive € 20.000 each)
BHF in collaboration with the KBF Fund Léonard and Fund Walckiers-Van Dessel
The call concerns non-commercial projects for basic research in the field of cardiovascular pathology. This research encompasses scientific disciplines such as biochemistry, physiology, and pharmacology and their interplay, and involves laboratory studies with cell cultures, animal studies or physiological experiments. Patients are not in the centre of the study but biological samples (e.g. blood) can be used for this purpose.
N° 2 – Clinical research in cardiology (the two best projects will receive € 20.000 each)
BHF in collaboration with the KBF Fund Léonard and Fund Walckiers-Van Dessel
The call concerns non-commercial projects for clinical research in the field of cardiovascular pathology. The research must be centred on the patients and aimed to determine the role of medication, intervention, diagnosis, symptoms or prevention in the physiological or pathological processes of the cardiovascular system.
N° 3 – Randomised clinical research trial (€75.000)
BHF in collaboration with the Fonds pour la Chirurgie Cardiaque / Fonds voor Hartchirurgie
The call concerns non-commercial projects for clinical research in the field of cardiovascular pathology. The research must be centred on the patients and aimed to explore the benefit of interventions (medical or non-medical) in patients with cardiovascular disease. The research should have a multicentre study design with randomisation between intervention and control . The research has to be carried out in at least two Belgian institutions, or more.
The Young Investigator Award with an associated prize of € 6,500 is given to individuals, whose research reflects new and relevant work in basic or clinical research in cardiology.
Basic Science: Justine Dontaine – UClouvain, Brussels
AMPK and O-GlcNAcylation: a new paradigm to protect the failing hypertrophic heart
Clinical: Lennert Minten – University Hospitals Leuven
Does coronary lesion complexity and pre-procedural revascularization affect 5-year outcomes in patients undergoing transcatheter aortic valve implantation?
Basic Science: Isabel Witvrouwen, UZ Antwerp
Micrornas as predictors for exercise response in heart failure with reduced ejection fraction
Clinical Science: Simon Calle, UZ Ghent
A strain-based staging classification of left bundle branch block-induced cardiac remodeling
Basic Science: Sander Trenson, UZ Leuven
Cardiac Microvascular Endothelial Cells in Pressure Overload-induced Heart Disease
Clinical Science: Jürgen Duchenne, UZ Leuven
Acute re-distribution of regional left ventricular work by cardiac resynchronization therapy
Basic Science: Kautbally Shakeel
Platelet acetyl-CoA carboxylase phosphorylation: a risk stratification marker evidencing platelet-lipid interplay in CAD patients
Basic Science: Peter Haemers
Basic Science: Guido Claessen
Right ventricular fatigue developing during endurance exercise: a real-time exercise cardiac magnetic resonance imaging study 2012 Clinical Science
Basic Science: Ward Heggermont, KU Leuven
Micro-RNA 146a: a new kid on the block in the pathophysiology of cardiac hypertension, and an interesting therapeutic target
Clinical Science: Alexandre Van De Bruaene, KU Leuven
Iron deficiency in patients with Eisenmenger’s syndrome: does it affect outcome, is oral anticoagulation involved and can there be too
Basic Science: Jozef Van Herck, UZ Antwerpen
Impaired elastin function promotes features of plaque instability in ApoE-deficient mice
Clinical Science: An Van Berendoncks, UZ Antwerpen
Circulating adiponectin levels in patients with chronic heart failure. The effect of exercise training
Basic Science: Pieter-Jan Guns, UZ Antwerpen
Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves endothelial cell function in apolipoprotein E-deficient mice with pre-existing atherosclerosis
Clinical Science: Johan Saenen, UZ Antwerpen
Multi-level study of the pathogenic mechanisms underlying the Long QT Syndrome
The Doctor Léon Dumont Prize of €40,000 is awarded every two years to an European researcher in cardiovascular medicine for clinical and experimental research projects.
Guido Claessen, UZ Leuven
PROSPECTIVE EVALUATION OF CARDIAC REMODELING IN YOUNG COMPETITIVE ATHLETES – IDENTIFICATION OF GENETIC AND ENVIRONMENTAL DETERMINANTS ([email protected]). THE PROSPECTIVE ATHLETE’S HEART ([email protected]) STUDY
Luc Bertrand – UCLouvain
Importance of protein O-GlcNAcylation in cardiac hypertrophy development
Sandrine Horman – UCLouvain
Limiting platelet lipid synthesis: a defense mechanism against atherothrombosis in coronary artery disease
The prize is awarded to non-commercial projects for basic research in the field of cardiovascular pathology. This research encompasses scientific disciplines such as biochemistry, physiology, and pharmacology and their interplay, and involves laboratory studies with cell cultures, animal studies or physiological experiments. Patients are not in the centre of the study but biological samples (e.g. blood) can be used for this purpose.
Aernout Luttun, KU Leuven
STUDY OF THE CELLULAR AND MOLECULAR MECHANISMS UNDERLYING CARDIOMYOPATHY CAUSED BY TRANSCRIPTION FACTOR PR DOMAIN CONTAINING 16 (PRDM16) DEFICIENCY IN CARDIOMYOCYTES AND NON-CARDIOMYOCYTE CELL TYPES
Jolanda van Hengel, UGhent
Generation and characterization of three novel induced pluripotent stem cell-derived cardiomyocyte lines as a model to study the pathophysiological mechanisms of arrhythmogenic cardiomyopathy
An Zwijsen – KU Leuven Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology (CMVB)
Contribution of BMP-SMAD regulated biogenesis of microRNAs in organ-specific functions of lymphatic endothelium
Alaerts Maaike – UZ Antwerp
Promising novel approach to Brugada syndrome research: identification of genetic modifiers using genome and transcriptome analysis in induced pluripotent stem cell-derived cardiomyocyte model
The prize is awarded to non-commercial projects for clinical research in the field of cardiovascular pathology. The research must be centred on the patients and aimed to determine the role of medication, intervention, diagnosis, symptoms or prevention in the physiological or pathological processes of the cardiovascular system.
Jan De Pooter, UZ Ghent
Conduction system pacing: a bench and bedside study. Insights in cardiac conduction disease translated to novel pacing strategies
Henri Gruwez, Ziekenhuis Oost-Limburg
SURGICAL-AF 2 study: The clinical impact of remote heart rhythm monitoring by photoplethysmography-based smartphone technology in the rehabilitation after cardiac surgery: A randomized, open-label, multicenter, pragmatic clinical trial
An Van Berendoncks – Antwerp University Hospital
Prevention of recurrence of hypertensive pregnancy disorders in women with active desire for pregnancy, a randomized controlled trial: a smartphone-based aerobic exercise training program during pregnancy versus usual care
Christophe Vandenbriele – KU Leuven
Mechanical circulatory support: a complex process of thrombosis and haemostasis
The prize is awarded to non-commercial projects in the field of cardio-oncology. The research can be centred on basic insights in cardio-oncology or cover broad aspects related to the clinical practice.
Lucas Van Aelst, UZ Leuven
PRECLINICAL AND CLINICAL ASSESSMENT OF THE BENEFICIAL EFFECTS OF HEPCIDIN, A PIVOTAL ENDOGENOUS REGULATOR OF IRON METABOLISM, ON ANTHRACYCLINE-INDUCED CARDIOTOXICITY
Gilles De Keulenaer, Antwerp University
Cardiovascular disease and cancer are linked through the NRG1/ERBB3 signaling system
Emeline Van Craenenbroeck – UZ Antwerp
Discovering the role of titin (TTN) in anthracycline-induced cardiac dysfunction in breast cancer.
The call is made for the first time and concerns non-commercial research projects in the field of sports cardiology and in the field of sudden cardiac death related to physical activities. The research can be centred on basic insights, or cover broad aspects related to the clinical practice.
Wendy Hens, UZ Antwerp
ECCENTRIC OVERLOAD TRAINING IN ADDITION TO A TRADITIONAL CARDIAC REHABILITATION PROGRAMME: RANDOMIZED CONTROLLED TRIAL TO EVALUATE EFFECTIVENESS AND FEASIBILITY IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION
An Van Berendoncks, UZ Antwerp
Supervised home-based combined endurance resistance exercise training programme in asymptomatic adult patients with congenital heart disease. A prospective randomised-controlled trial to evaluate effectiveness, safety and quality of life